BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 8091823)

  • 1. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
    Mitrovic V; Neuzner J; Opper H; Thormann J; Schlepper M
    Z Kardiol; 1994; 83 Suppl 2():37-48. PubMed ID: 8091823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
    Saborowski F; Peters P; Schneider M
    Z Kardiol; 1991; 80 Suppl 4():63-7. PubMed ID: 1833900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose enoximone therapy in pre-transplant patients: hemodynamic, echocardiographic, and neurohumoral findings.
    Park JW; Heinzler R; Wirtz JH; Fieten-Rumswinkel M; Braun P; May E; Hetzer R; Heinrich KW
    Z Kardiol; 1994; 83 Suppl 2():49-53. PubMed ID: 8091824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enoximone in the postoperative phase of heart surgery].
    Hachenberg T
    Z Kardiol; 1994; 83 Suppl 2():63-8. PubMed ID: 8091826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the hemodynamic effect of enoximone and dopamine in patients after coronary bypass operation].
    Birnbaum DE; Preuner JG; Gieseke R; Kasper-König W; Trenk D; Jähnchen E; Dieterich HA
    Z Kardiol; 1991; 80 Suppl 4():47-52. PubMed ID: 1833897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of low cardiac output syndrome in newborn infants and children].
    Hausdorf G; Loebe M
    Z Kardiol; 1994; 83 Suppl 2():91-100. PubMed ID: 8091831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of enoximone in patients with acute and subacute heart failure in the intensive care unit].
    Holubarsch C; Pieske B; Hasenfuss G; Just H
    Z Kardiol; 1994; 83 Suppl 2():21-5. PubMed ID: 8091821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
    Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
    J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic effects and comparison of enoximone, dobutamine and dopamine following mitral valve surgery.
    Tarr TJ; Moore NA; Frazer RS; Shearer ES; Desmond MJ
    Eur J Anaesthesiol Suppl; 1993; 8():15-24. PubMed ID: 8223351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
    Galinier M; Rochiccioli JP; Edouard P; Fourcade J; Massabuau P; Puel J; Fauvel JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():27-32. PubMed ID: 2147831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure.
    Nakano T; Morimoto Y; Kakuta Y; Konishi T; Kodera T; Kanamaru M; Takezawa H
    Arzneimittelforschung; 1986 Dec; 36(12):1829-34. PubMed ID: 3551968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of new cardiac agents using differential therapeutic criteria].
    Redmann K; Lunkenheimer PP; Rettig G; Isringhaus H; Flameng W; Demeyere R
    Z Kardiol; 1991; 80 Suppl 4():7-14. PubMed ID: 1833902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/dobutamine].
    Meissner A; Schmelzle T; Simon R
    Z Kardiol; 1996 Nov; 85(11):839-46. PubMed ID: 9064946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atrial natriuretic factor, catecholamines and the renin-angiotensin system in cardiac insufficiency. Relation to hemodynamic parameters].
    Komajda M; Carayon A; Nguyen JP; Maistre G; Drobinski G; Legrand S; Landault C; Legrand JC; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1988 Jul; 81(7):845-53. PubMed ID: 2973293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of enoximone in chronic heart failure.
    Saborowski F; Peters P; Schneider M; Fehske W; Dieterich HA
    J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S57-61. PubMed ID: 2480487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of dopexamine on the hemodynamics of coronary surgery patients with and without bisoprolol blockade].
    Günnicker M; Freund U; Grebe EJ; Scherer R; Schieffer M; Zerkowski HR; Hess W
    Z Kardiol; 1993 Nov; 82(11):729-36. PubMed ID: 7904788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dose-response relation of intravenous enoximone in congestive cardiac insufficiency].
    Lellouche D; Delorme G; Merlet P; Dubois-Randé JL; Duval AM; Tarral A; Bourdarias JP; Vernant P
    Arch Mal Coeur Vaiss; 1988 Sep; 81(9):1107-13. PubMed ID: 2973777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Additive effects of milrinone and dobutamine in severe heart failure].
    Meissner A; Herrmann G; Gerdesmeyer L; Simon R
    Z Kardiol; 1992 May; 81(5):266-71. PubMed ID: 1621407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.